Asia-Pacific Biotechnicss Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 11-07-2024
- Paid Up Capital ₹ 9.50 M
as on 11-07-2024
- Company Age 18 Year, 20 Days
- Last Filing with ROC 31 Mar 2023
- Revenue 80.85%
(FY 2017)
- Profit -67.72%
(FY 2017)
- Ebitda 1925.96%
(FY 2017)
- Net Worth 1.63%
(FY 2017)
- Total Assets 0.73%
(FY 2017)
About Asia-Pacific Biotechnicss
The Corporate was formerly known as Asia-Pacific Biotechnicss Limited. The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 9.50 M, as per Ministry of Corporate Affairs (MCA) records.
Dharmendra Singh and Shubham Singh serve as directors at the Company.
- CIN/LLPIN
U45100UP2006PTC032584
- Company No.
032584
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Dec 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Asia-Pacific Biotechnicss?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shubham Singh  | Director | 10-Mar-2017 | Current |
| Dharmendra Singh | Director | 12-Jan-2017 | Current |
Financial Performance of Asia-Pacific Biotechnicss.
Asia-Pacific Biotechnicss Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 80.85% increase. The company also saw a substantial fall in profitability, with a 67.72% decrease in profit. The company's net worth moved up by a moderate rise of 1.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Asia-Pacific Biotechnicss?
In 2017, Asia-Pacific Biotechnicss had a promoter holding of 7.37% and a public holding of 92.63%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Rae Bareli Infrastructure Private LimitedActive 14 years 15 daysDharmendra Singh and Shubham Singh are mutual person
- Runjhun Enterprises (India) Private LimitedActive 32 years 2 months
Dharmendra Singh is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Asia-Pacific Biotechnicss?
Unlock and access historical data on people associated with Asia-Pacific Biotechnicss, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Asia-Pacific Biotechnicss, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Asia-Pacific Biotechnicss's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
